[1]
J. de Soto, “The Treatment of Clear Cell Ovarian Cancer with the Poly(ADP- Ribose) Polymerase (PARP1) Inhibitors (AG14361,Veliparib,Olaparib) as Chemosensitizers. : The Treatment of Clear Cell Ovarian Cancer with PARP inhibitors”, J Current Med Res Opinion, vol. 3, no. 11, pp. 732–738, Nov. 2020.